US20050164241A1 - Non-invasive detection of fetal genetic traits - Google Patents
Non-invasive detection of fetal genetic traits Download PDFInfo
- Publication number
- US20050164241A1 US20050164241A1 US10/964,726 US96472604A US2005164241A1 US 20050164241 A1 US20050164241 A1 US 20050164241A1 US 96472604 A US96472604 A US 96472604A US 2005164241 A1 US2005164241 A1 US 2005164241A1
- Authority
- US
- United States
- Prior art keywords
- fetal
- dna
- sample
- disorder
- genetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000001605 fetal effect Effects 0.000 title claims abstract description 63
- 230000002068 genetic effect Effects 0.000 title claims abstract description 31
- 238000001514 detection method Methods 0.000 title claims abstract description 15
- 239000000523 sample Substances 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 23
- 210000002381 plasma Anatomy 0.000 claims abstract description 20
- 208000031404 Chromosome Aberrations Diseases 0.000 claims abstract description 14
- 231100000005 chromosome aberration Toxicity 0.000 claims abstract description 14
- 238000000926 separation method Methods 0.000 claims abstract description 14
- 230000035935 pregnancy Effects 0.000 claims abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 10
- 208000026350 Inborn Genetic disease Diseases 0.000 claims abstract description 9
- 208000016361 genetic disease Diseases 0.000 claims abstract description 9
- 210000002966 serum Anatomy 0.000 claims abstract description 8
- 210000001766 X chromosome Anatomy 0.000 claims abstract description 7
- 210000002593 Y chromosome Anatomy 0.000 claims abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims abstract description 6
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 6
- 101150108975 Rhd gene Proteins 0.000 claims abstract description 5
- 238000009396 hybridization Methods 0.000 claims abstract description 4
- 238000003499 nucleic acid array Methods 0.000 claims abstract description 4
- 238000000432 density-gradient centrifugation Methods 0.000 claims abstract description 3
- 239000003446 ligand Substances 0.000 claims abstract 2
- 238000003752 polymerase chain reaction Methods 0.000 claims description 14
- 238000001962 electrophoresis Methods 0.000 claims description 8
- 208000024556 Mendelian disease Diseases 0.000 claims description 7
- 239000000499 gel Substances 0.000 claims description 7
- 201000003883 Cystic fibrosis Diseases 0.000 claims description 6
- 208000036878 aneuploidy Diseases 0.000 claims description 6
- 231100001075 aneuploidy Toxicity 0.000 claims description 6
- 208000035475 disorder Diseases 0.000 claims description 6
- 208000034737 hemoglobinopathy Diseases 0.000 claims description 6
- 201000010374 Down Syndrome Diseases 0.000 claims description 5
- 206010044688 Trisomy 21 Diseases 0.000 claims description 5
- 210000003754 fetus Anatomy 0.000 claims description 5
- 208000001914 Fragile X syndrome Diseases 0.000 claims description 4
- 208000031220 Hemophilia Diseases 0.000 claims description 4
- 208000009292 Hemophilia A Diseases 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 claims description 4
- 239000003550 marker Substances 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 238000005251 capillar electrophoresis Methods 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 230000002949 hemolytic effect Effects 0.000 claims description 3
- 229920000936 Agarose Polymers 0.000 claims description 2
- 230000000274 adsorptive effect Effects 0.000 claims description 2
- 238000003491 array Methods 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 238000004249 ion pair reversed phase high performance liquid chromatography Methods 0.000 claims description 2
- 238000007834 ligase chain reaction Methods 0.000 claims description 2
- 239000011159 matrix material Substances 0.000 claims description 2
- 238000011140 membrane chromatography Methods 0.000 claims description 2
- 238000004226 microchip electrophoresis Methods 0.000 claims description 2
- 229920002401 polyacrylamide Polymers 0.000 claims description 2
- 238000004007 reversed phase HPLC Methods 0.000 claims description 2
- 230000008774 maternal effect Effects 0.000 abstract description 28
- 108020004414 DNA Proteins 0.000 description 66
- 108700028369 Alleles Proteins 0.000 description 10
- 239000012634 fragment Substances 0.000 description 8
- 108091092878 Microsatellite Proteins 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000008775 paternal effect Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000003321 amplification Effects 0.000 description 4
- 210000000349 chromosome Anatomy 0.000 description 4
- 208000018337 inherited hemoglobinopathy Diseases 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 208000018712 Hemolytic disease due to fetomaternal alloimmunization Diseases 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 238000007399 DNA isolation Methods 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 101150112014 Gapdh gene Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000007857 nested PCR Methods 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 238000005382 thermal cycling Methods 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Definitions
- fetal genetic loci e.g. chromosomal aberrations such as aneuploidies or chromosomal aberrations associated with Down's syndrome, or hereditary Mendelian genetic disorders and, respectively, genetic markers associated therewith, such as single gene disorders, e.g. cystic fibrosis or the hemoglobinopathies
- the reason for this difficulty is that the major proportion (generally>90%) of the extracellular DNA in the maternal circulation is derived from the mother.
- This vast bulk of maternal circulatory extracellular DNA renders it difficult, if not impossible, to determine fetal genetic alternations such as those involved in chromosomal aberrations (e.g. aneuploidies) or hereditary Mendelian genetic disorders (e.g. cystic fibrosis or the hemoglobinopathies) from the small amount of circulatory extracellular fetal DNA.
- This selective enrichment which is based on size discrimination of circulatory DNA fragments of approximately 500 base pairs or less, leads to a fraction which is largely constituted by fetal extracellular DNA.
- Size separation of extracellular fetal DNA in the maternal circulation thus facilitates the non-invasive detection of fetal genetic traits, including paternally inherited polymorphisms which permit paternity testing.
- the present invention provides
- Said serum or plasma sample is preferably substantially cell-free, and this can be achieved by known methods such as, for example, centrifugation or sterile filtration.
- the size separation of the extracellular DNA in said serum or plasma sample can be brought about by a variety of methods, including but not limited to
- the sample-fraction thus obtained not only permits the subsequent determination of fetal genetic traits which had already been easily detectable in a conventional manner such as the fetal RhD gene in pregnancies at risk for HDN (hemolytic disease of the fetus and the newborn), or fetal Y chromosome-specific sequences in pregnancies at risk for an X chromosome-linked disorder such as hemophilia, fragile X syndrome or the like, but also the determination of other, more complex fetal genetic loci, including but not limited to
- Such determination of fetal genetic traits can be effected by methods such as, for example, PCR (polymerase chain reaction) technology, ligase chain reaction, probe hybridisation techniques, nucleic acid arrays (so-called “DNA chips”) and the like.
- DNA from 5-7 ml plasma was extracted using the QIAgen Maxi kit, according to the manufacturers' protocol. DNA was eluted in a volume of 1.5 ml.
- Sequences from the Y chromosome (SRY) and from chromosome 12 (GAPDH gene) were amplified with the Applied Biosystems (ABI) 7000 Sequence Detection System by real-time quantitative PCR to quantify amounts of fetal and total DNA in the size-separated fractions.
- the TaqMan system for SRY consisted of the amplification primers SRY_Fwd: TCC TCA AAA GAA ACC GTG CAT and SRY_Rev: AGA TTA ATG GTT GCT AAG GAC TGG AT and a FAM labeled TaqMan MGB (Minor Groove Binder) probe SRY_MGB: TCC CCA CAA CCT CTT.
- the TaqMan System for the GAPDH gene consisted of the following primers and probe: GAPDH_Fwd: CCC CAC ACA CAT GCA CTT ACC, GAPDH_Rev: CCT AGT CCC AGG GCT TTG ATT and GAPDH_MGB: TAG GAA GGA CAG GCA AC.
- TaqMan amplification reactions were set up in a total reaction volume of 25 ⁇ l, containing 6 ⁇ l of the sample DNA solution, 300 nM of each primer (HPLC purified, Mycrosynth, Switzerland) and 200 nM of each probe (ABI) at 1 ⁇ concentration of the Universal PCR reaction mix (ABI). Each sample was analyzed in duplicate for each of the two amplification systems. A standard curve containing known amounts of genomic DNA was run in parallel with each analysis.
- Thermal cycling was performed according to the following protocol: An initial incubation at 50° C. for 2 minutes to permit Amp Erase activity, 10 minutes at 95° C. for activation of AmpliTaq Gold, and 40 cycles of 1 minute at 60° C. and 15 seconds at 95° C.
- Amplification data collected by the 7000 Sequence Detection System was quantified using the slope of the standard curve as calculated by the sequence detection software and the results of a standard DNA solution used in the dilution curve with similar DNA copy numbers as the sample reactions as a reference sample for copy number calculations.
- Table 1 shows that in the five pregnancies examined, DNA fragments originating from the fetus were almost completely of sizes smaller than 500 base pairs with around 70% being of fetal origin for sizes smaller than 300 bases.
- DNA from the plasma was extracted using a modification of the High Pure DNA template kit from Roche, the whole sample was passed through the filter usually used for 200 ⁇ l using a vacuum. The DNA was eluted in a volume of 50 ⁇ l elution buffer.
- Paternal DNA was extracted from 400 ⁇ l paternal whole blood, using the High Pure DNA template kit, and eluted into 100 ⁇ l. Maternal DNA was isolated from the buffy coat, using the High Pure DNA template kit, and eluted into 100 ⁇ l.
- the DNA was size-separated by electrophoresis on an agarose gel and purified as described in Example 1.
- sequences from tetranucleotide repeat markers on Chromosome 21 were amplified in a multiplex PCR reaction as described in Li et al. Clinical Chemistry 49, No. 4, 2003. Because of the low concentration of plasma DNA, the fetal DNA in maternal plasma was examined by using a semi-nested PCR protocol.
- the maternal and paternal pairs were genotyped using total genomic DNA to monitor microsatellite markers on chromosome 21.
- the STR markers used were:
- the resulting DNA fragments were then size separated by capillary electrophoresis on a sequencer, and the peak areas representing each allele for a specific marker were measured by the software.
- Analysis of the STR fragments can allow for the detection of paternal alleles that are distinct in length from the maternal repeat sequences, and by calculating the ratios between the peak areas it can be possible to identify patterns that are not consistent with a normal fetal karyotype.
- the identification of paternal allele sizes of STRs in the maternal circulation can allow the detection of certain chromosomal aberrations non-invasively. Also paternity testing can be accomplished prenatal in a non-invasive manner.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/855,558 US7838647B2 (en) | 2003-10-16 | 2007-09-14 | Non-invasive detection of fetal genetic traits |
US13/029,999 US20110245482A1 (en) | 2003-10-16 | 2011-02-17 | Non-invasive detection of fetal genetic traits |
US13/029,995 US9580751B2 (en) | 2003-10-16 | 2011-02-17 | Non-invasive detection of fetal genetic traits |
US13/557,025 US20120302741A1 (en) | 2003-10-16 | 2012-07-24 | Non-invasive detection of fetal genetic traits |
US13/757,637 US9738931B2 (en) | 2003-10-16 | 2013-02-01 | Non-invasive detection of fetal genetic traits |
US13/779,300 US20130190483A1 (en) | 2003-10-16 | 2013-02-27 | Non-invasive detection of fetal genetic traits |
US15/653,401 US20170321279A1 (en) | 2003-10-16 | 2017-07-18 | Non-invasive detection of fetal genetic traits |
US17/317,240 US20210262035A1 (en) | 2003-10-16 | 2021-05-11 | Non-invasive detection of fetal genetic traits |
US18/538,488 US20240182970A1 (en) | 2003-10-16 | 2023-12-13 | Non-invasive detection of fetal genetic traits |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03405742.2 | 2003-10-16 | ||
EP03405742.2A EP1524321B2 (en) | 2003-10-16 | 2003-10-16 | Non-invasive detection of fetal genetic traits |
Related Child Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/855,558 Division US7838647B2 (en) | 2003-10-16 | 2007-09-14 | Non-invasive detection of fetal genetic traits |
US13/029,995 Division US9580751B2 (en) | 2003-10-16 | 2011-02-17 | Non-invasive detection of fetal genetic traits |
US13/029,999 Continuation US20110245482A1 (en) | 2003-10-16 | 2011-02-17 | Non-invasive detection of fetal genetic traits |
US13/557,025 Continuation US20120302741A1 (en) | 2003-10-16 | 2012-07-24 | Non-invasive detection of fetal genetic traits |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050164241A1 true US20050164241A1 (en) | 2005-07-28 |
Family
ID=34354635
Family Applications (10)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/964,726 Abandoned US20050164241A1 (en) | 2003-10-16 | 2004-10-15 | Non-invasive detection of fetal genetic traits |
US11/855,558 Active 2026-03-09 US7838647B2 (en) | 2003-10-16 | 2007-09-14 | Non-invasive detection of fetal genetic traits |
US13/029,999 Abandoned US20110245482A1 (en) | 2003-10-16 | 2011-02-17 | Non-invasive detection of fetal genetic traits |
US13/029,995 Active US9580751B2 (en) | 2003-10-16 | 2011-02-17 | Non-invasive detection of fetal genetic traits |
US13/557,025 Abandoned US20120302741A1 (en) | 2003-10-16 | 2012-07-24 | Non-invasive detection of fetal genetic traits |
US13/757,637 Active 2026-02-22 US9738931B2 (en) | 2003-10-16 | 2013-02-01 | Non-invasive detection of fetal genetic traits |
US13/779,300 Abandoned US20130190483A1 (en) | 2003-10-16 | 2013-02-27 | Non-invasive detection of fetal genetic traits |
US15/653,401 Abandoned US20170321279A1 (en) | 2003-10-16 | 2017-07-18 | Non-invasive detection of fetal genetic traits |
US17/317,240 Pending US20210262035A1 (en) | 2003-10-16 | 2021-05-11 | Non-invasive detection of fetal genetic traits |
US18/538,488 Pending US20240182970A1 (en) | 2003-10-16 | 2023-12-13 | Non-invasive detection of fetal genetic traits |
Family Applications After (9)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/855,558 Active 2026-03-09 US7838647B2 (en) | 2003-10-16 | 2007-09-14 | Non-invasive detection of fetal genetic traits |
US13/029,999 Abandoned US20110245482A1 (en) | 2003-10-16 | 2011-02-17 | Non-invasive detection of fetal genetic traits |
US13/029,995 Active US9580751B2 (en) | 2003-10-16 | 2011-02-17 | Non-invasive detection of fetal genetic traits |
US13/557,025 Abandoned US20120302741A1 (en) | 2003-10-16 | 2012-07-24 | Non-invasive detection of fetal genetic traits |
US13/757,637 Active 2026-02-22 US9738931B2 (en) | 2003-10-16 | 2013-02-01 | Non-invasive detection of fetal genetic traits |
US13/779,300 Abandoned US20130190483A1 (en) | 2003-10-16 | 2013-02-27 | Non-invasive detection of fetal genetic traits |
US15/653,401 Abandoned US20170321279A1 (en) | 2003-10-16 | 2017-07-18 | Non-invasive detection of fetal genetic traits |
US17/317,240 Pending US20210262035A1 (en) | 2003-10-16 | 2021-05-11 | Non-invasive detection of fetal genetic traits |
US18/538,488 Pending US20240182970A1 (en) | 2003-10-16 | 2023-12-13 | Non-invasive detection of fetal genetic traits |
Country Status (5)
Country | Link |
---|---|
US (10) | US20050164241A1 (ja) |
EP (1) | EP1524321B2 (ja) |
JP (3) | JP4705774B2 (ja) |
AT (1) | ATE435301T1 (ja) |
DE (1) | DE60328193D1 (ja) |
Cited By (141)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007140417A2 (en) | 2006-05-31 | 2007-12-06 | Sequenom, Inc. | Methods and compositions for the extraction and amplification of nucleic acid from a sample |
US20080020390A1 (en) * | 2006-02-28 | 2008-01-24 | Mitchell Aoy T | Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms |
US20080071076A1 (en) * | 2003-10-16 | 2008-03-20 | Sequenom, Inc. | Non-invasive detection of fetal genetic traits |
US20080070792A1 (en) * | 2006-06-14 | 2008-03-20 | Roland Stoughton | Use of highly parallel snp genotyping for fetal diagnosis |
US20080096766A1 (en) * | 2006-06-16 | 2008-04-24 | Sequenom, Inc. | Methods and compositions for the amplification, detection and quantification of nucleic acid from a sample |
US20080220422A1 (en) * | 2006-06-14 | 2008-09-11 | Daniel Shoemaker | Rare cell analysis using sample splitting and dna tags |
US20090029377A1 (en) * | 2007-07-23 | 2009-01-29 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing |
US20090203002A1 (en) * | 2006-03-06 | 2009-08-13 | Columbia University | Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures |
US20090317797A1 (en) * | 2005-01-18 | 2009-12-24 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Non-Invasive, Prenatal, In-Vitro Method for Detecting the Normal Healthy Condition, the Condition of a Healthy Carrier or the Condition of a Carrier Inflicted with Cystic Fibrosis |
US20090317817A1 (en) * | 2008-03-11 | 2009-12-24 | Sequenom, Inc. | Nucleic acid-based tests for prenatal gender determination |
US20100112590A1 (en) * | 2007-07-23 | 2010-05-06 | The Chinese University Of Hong Kong | Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing With Enrichment |
US20100124751A1 (en) * | 2006-02-02 | 2010-05-20 | The Board Of Trustees Of The Leland Stanford Junior University | Non-Invasive Fetal Genetic Screening by Digital Analysis |
US20100184044A1 (en) * | 2006-02-28 | 2010-07-22 | University Of Louisville Research Foundation | Detecting Genetic Abnormalities |
US20100184043A1 (en) * | 2006-02-28 | 2010-07-22 | University Of Louisville Research Foundation | Detecting Genetic Abnormalities |
US20100261188A1 (en) * | 2006-12-07 | 2010-10-14 | Biocept, Inc. | Non-invasive prenatal genetic screen |
US20110033862A1 (en) * | 2008-02-19 | 2011-02-10 | Gene Security Network, Inc. | Methods for cell genotyping |
WO2011034631A1 (en) | 2009-09-16 | 2011-03-24 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
US20110092763A1 (en) * | 2008-05-27 | 2011-04-21 | Gene Security Network, Inc. | Methods for Embryo Characterization and Comparison |
US20110105353A1 (en) * | 2009-11-05 | 2011-05-05 | The Chinese University of Hong Kong c/o Technology Licensing Office | Fetal Genomic Analysis From A Maternal Biological Sample |
WO2011054936A1 (en) | 2009-11-06 | 2011-05-12 | The Chinese University Of Hong Kong | Size-based genomic analysis |
US20110117548A1 (en) * | 2006-02-28 | 2011-05-19 | University Of Louisville Research Foundation, Inc. | Detecting Fetal Chromosomal Abnormalities Using Tandem Single Nucleotide Polymorphisms |
US20110130558A1 (en) * | 2008-05-30 | 2011-06-02 | Qiagen Gmbh | Method for isolating nucleic acids |
US20110129841A1 (en) * | 2005-06-02 | 2011-06-02 | Fluidigm Corporation | Analysis using microfluidic partitioning devices |
US20110178719A1 (en) * | 2008-08-04 | 2011-07-21 | Gene Security Network, Inc. | Methods for Allele Calling and Ploidy Calling |
WO2011156387A2 (en) | 2010-06-07 | 2011-12-15 | Esoterix Genetic Laboratories, Llc | Enumeration of nucleic acids |
WO2012012725A2 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting diseases or conditions using phagocytic cells |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
US8195415B2 (en) | 2008-09-20 | 2012-06-05 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
WO2012114075A1 (en) | 2011-02-25 | 2012-08-30 | University Of Plymouth | Method for processing maternal and fetal dna |
US8426122B2 (en) | 2010-03-11 | 2013-04-23 | Cellscape Corporation | Method and device for identification of nucleated red blood cells from a maternal blood sample |
WO2013075100A1 (en) * | 2011-11-17 | 2013-05-23 | Cellscape Corporation | Methods, devices, and kits for obtaining and analyzing cells |
US8450061B2 (en) | 2011-04-29 | 2013-05-28 | Sequenom, Inc. | Quantification of a minority nucleic acid species |
US8518228B2 (en) | 2011-05-20 | 2013-08-27 | The University Of British Columbia | Systems and methods for enhanced SCODA |
US8529744B2 (en) | 2004-02-02 | 2013-09-10 | Boreal Genomics Corp. | Enrichment of nucleic acid targets |
WO2014011928A1 (en) | 2012-07-13 | 2014-01-16 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
US8652780B2 (en) | 2007-03-26 | 2014-02-18 | Sequenom, Inc. | Restriction endonuclease enhanced polymorphic sequence detection |
US8682592B2 (en) | 2005-11-26 | 2014-03-25 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US8722336B2 (en) | 2008-03-26 | 2014-05-13 | Sequenom, Inc. | Restriction endonuclease enhanced polymorphic sequence detection |
US8771948B2 (en) | 2009-04-03 | 2014-07-08 | Sequenom, Inc. | Nucleic acid preparation compositions and methods |
US8825412B2 (en) | 2010-05-18 | 2014-09-02 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US8852416B2 (en) | 2008-02-01 | 2014-10-07 | The University Of British Columbia | Methods and apparatus for particle introduction and recovery |
US8877028B2 (en) | 2009-04-21 | 2014-11-04 | The University Of British Columbia | System and methods for detection of particles |
US8962247B2 (en) | 2008-09-16 | 2015-02-24 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
US9163282B2 (en) | 2010-05-18 | 2015-10-20 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US9186685B2 (en) | 2012-01-13 | 2015-11-17 | The University Of British Columbia | Multiple arm apparatus and methods for separation of particles |
US9228234B2 (en) | 2009-09-30 | 2016-01-05 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US9340835B2 (en) | 2013-03-15 | 2016-05-17 | Boreal Genomics Corp. | Method for separating homoduplexed and heteroduplexed nucleic acids |
US9367663B2 (en) | 2011-10-06 | 2016-06-14 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US9499870B2 (en) | 2013-09-27 | 2016-11-22 | Natera, Inc. | Cell free DNA diagnostic testing standards |
US9512477B2 (en) | 2012-05-04 | 2016-12-06 | Boreal Genomics Inc. | Biomarker anaylsis using scodaphoresis |
EP3103871A1 (en) | 2008-09-16 | 2016-12-14 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnostic |
US9534304B2 (en) | 2004-02-02 | 2017-01-03 | The University Of British Columbia | Scodaphoresis and methods and apparatus for moving and concentrating particles |
US9547748B2 (en) | 2011-06-29 | 2017-01-17 | Bgi Health Service Co., Ltd. | Method for determining fetal chromosomal abnormality |
US9598731B2 (en) | 2012-09-04 | 2017-03-21 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US9605313B2 (en) | 2012-03-02 | 2017-03-28 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US9840732B2 (en) | 2012-05-21 | 2017-12-12 | Fluidigm Corporation | Single-particle analysis of particle populations |
US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
US9902992B2 (en) | 2012-09-04 | 2018-02-27 | Guardant Helath, Inc. | Systems and methods to detect rare mutations and copy number variation |
US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
US9920366B2 (en) | 2013-12-28 | 2018-03-20 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
US9926593B2 (en) | 2009-12-22 | 2018-03-27 | Sequenom, Inc. | Processes and kits for identifying aneuploidy |
US9984198B2 (en) | 2011-10-06 | 2018-05-29 | Sequenom, Inc. | Reducing sequence read count error in assessment of complex genetic variations |
US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
US10081839B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc | System and method for cleaning noisy genetic data and determining chromosome copy number |
US10083273B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US10106836B2 (en) | 2013-03-15 | 2018-10-23 | The Chinese University Of Hong Kong | Determining fetal genomes for multiple fetus pregnancies |
US10113196B2 (en) | 2010-05-18 | 2018-10-30 | Natera, Inc. | Prenatal paternity testing using maternal blood, free floating fetal DNA and SNP genotyping |
US10179937B2 (en) | 2014-04-21 | 2019-01-15 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
US10196681B2 (en) | 2011-10-06 | 2019-02-05 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10240209B2 (en) | 2015-02-10 | 2019-03-26 | The Chinese University Of Hong Kong | Detecting mutations for cancer screening |
US10262755B2 (en) | 2014-04-21 | 2019-04-16 | Natera, Inc. | Detecting cancer mutations and aneuploidy in chromosomal segments |
US20190169681A1 (en) * | 2010-08-06 | 2019-06-06 | Ariosa Diagnostics, Inc. | Assay systems for genetic analysis |
US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US10337054B2 (en) | 2004-02-02 | 2019-07-02 | Quantum-Si Incorporated | Enrichment of nucleic acid targets |
US10364467B2 (en) | 2015-01-13 | 2019-07-30 | The Chinese University Of Hong Kong | Using size and number aberrations in plasma DNA for detecting cancer |
US10424394B2 (en) | 2011-10-06 | 2019-09-24 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10438691B2 (en) | 2013-10-07 | 2019-10-08 | Sequenom, Inc. | Non-invasive assessment of chromosome alterations using change in subsequence mappability |
US10482994B2 (en) | 2012-10-04 | 2019-11-19 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10494675B2 (en) | 2013-03-09 | 2019-12-03 | Cell Mdx, Llc | Methods of detecting cancer |
US10497462B2 (en) | 2013-01-25 | 2019-12-03 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10497461B2 (en) | 2012-06-22 | 2019-12-03 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10504613B2 (en) | 2012-12-20 | 2019-12-10 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10526658B2 (en) | 2010-05-18 | 2020-01-07 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US10577655B2 (en) | 2013-09-27 | 2020-03-03 | Natera, Inc. | Cell free DNA diagnostic testing standards |
US10591391B2 (en) | 2006-06-14 | 2020-03-17 | Verinata Health, Inc. | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
US10622094B2 (en) | 2013-06-21 | 2020-04-14 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
EP3636776A1 (en) | 2010-02-19 | 2020-04-15 | Sequenom, Inc. | Methods for analysing nucleic acid sequence information using gc bias, optionally for detecting fetal nucleic acid abnormalities |
US10626464B2 (en) | 2014-09-11 | 2020-04-21 | Cell Mdx, Llc | Methods of detecting prostate cancer |
US10633713B2 (en) | 2017-01-25 | 2020-04-28 | The Chinese University Of Hong Kong | Diagnostic applications using nucleic acid fragments |
US10662474B2 (en) | 2010-01-19 | 2020-05-26 | Verinata Health, Inc. | Identification of polymorphic sequences in mixtures of genomic DNA by whole genome sequencing |
US10699800B2 (en) | 2013-05-24 | 2020-06-30 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10704085B2 (en) | 2014-03-05 | 2020-07-07 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10894976B2 (en) | 2017-02-21 | 2021-01-19 | Natera, Inc. | Compositions, methods, and kits for isolating nucleic acids |
US10930368B2 (en) | 2013-04-03 | 2021-02-23 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10934589B2 (en) | 2008-01-18 | 2021-03-02 | President And Fellows Of Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
US10964409B2 (en) | 2013-10-04 | 2021-03-30 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10961578B2 (en) | 2010-07-23 | 2021-03-30 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
US11004537B2 (en) | 2011-06-24 | 2021-05-11 | Sequenom, Inc. | Methods and processes for non invasive assessment of a genetic variation |
US11001884B2 (en) | 2011-10-06 | 2021-05-11 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US11060145B2 (en) | 2013-03-13 | 2021-07-13 | Sequenom, Inc. | Methods and compositions for identifying presence or absence of hypermethylation or hypomethylation locus |
US11111537B2 (en) | 2010-07-23 | 2021-09-07 | President And Fellows Of Harvard College | Methods of detecting autoimmune or immune-related diseases or conditions |
US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US11130986B2 (en) | 2015-05-20 | 2021-09-28 | Quantum-Si Incorporated | Method for isolating target nucleic acid using heteroduplex binding proteins |
US11168351B2 (en) | 2015-03-05 | 2021-11-09 | Streck, Inc. | Stabilization of nucleic acids in urine |
US11200963B2 (en) | 2016-07-27 | 2021-12-14 | Sequenom, Inc. | Genetic copy number alteration classifications |
WO2021174079A3 (en) * | 2020-02-28 | 2021-12-16 | Laboratory Corporation Of America Holdings | Compositions, methods, and systems for paternity determination |
US11232850B2 (en) | 2017-03-24 | 2022-01-25 | Myriad Genetics, Inc. | Copy number variant caller |
US11242569B2 (en) | 2015-12-17 | 2022-02-08 | Guardant Health, Inc. | Methods to determine tumor gene copy number by analysis of cell-free DNA |
US11261494B2 (en) | 2012-06-21 | 2022-03-01 | The Chinese University Of Hong Kong | Method of measuring a fractional concentration of tumor DNA |
US11299764B2 (en) | 2015-11-20 | 2022-04-12 | Streck, Inc. | Single spin process for blood plasma separation and plasma composition including preservative |
US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11326204B2 (en) | 2013-08-19 | 2022-05-10 | Invitae Corporation | Assays for single molecule detection and use thereof |
US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11352670B2 (en) | 2014-07-25 | 2022-06-07 | University Of Washington | Methods of determining tissues and/or cell types giving rise to cell-free DNA, and methods of identifying a disease or disorder using same |
US11365447B2 (en) | 2014-03-13 | 2022-06-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
US11459616B2 (en) | 2016-10-24 | 2022-10-04 | The Chinese University Of Hong Kong | Methods and systems for tumor detection |
US11479812B2 (en) | 2015-05-11 | 2022-10-25 | Natera, Inc. | Methods and compositions for determining ploidy |
US11485996B2 (en) | 2016-10-04 | 2022-11-01 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
US11506655B2 (en) | 2016-07-29 | 2022-11-22 | Streck, Inc. | Suspension composition for hematology analysis control |
US11525159B2 (en) | 2018-07-03 | 2022-12-13 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
US11585814B2 (en) | 2013-03-09 | 2023-02-21 | Immunis.Ai, Inc. | Methods of detecting prostate cancer |
US11694768B2 (en) | 2017-01-24 | 2023-07-04 | Sequenom, Inc. | Methods and processes for assessment of genetic variations |
US11697849B2 (en) | 2012-01-20 | 2023-07-11 | Sequenom, Inc. | Methods for non-invasive assessment of fetal genetic variations that factor experimental conditions |
US11708574B2 (en) | 2016-06-10 | 2023-07-25 | Myriad Women's Health, Inc. | Nucleic acid sequencing adapters and uses thereof |
US11739371B2 (en) | 2015-02-18 | 2023-08-29 | Invitae Corporation | Arrays for single molecule detection and use thereof |
US11783911B2 (en) | 2014-07-30 | 2023-10-10 | Sequenom, Inc | Methods and processes for non-invasive assessment of genetic variations |
US11854666B2 (en) | 2016-09-29 | 2023-12-26 | Myriad Women's Health, Inc. | Noninvasive prenatal screening using dynamic iterative depth optimization |
EP4303584A2 (en) | 2010-07-23 | 2024-01-10 | President and Fellows of Harvard College | Methods for detecting signatures of disease or conditions in bodily fluids |
US11913065B2 (en) | 2012-09-04 | 2024-02-27 | Guardent Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US12011716B2 (en) | 2019-10-29 | 2024-06-18 | Quantum-Si Incorporated | Peristaltic pumping of fluids and associated methods, systems, and devices |
US12024738B2 (en) | 2018-04-14 | 2024-07-02 | Natera, Inc. | Methods for cancer detection and monitoring |
US12084720B2 (en) | 2017-12-14 | 2024-09-10 | Natera, Inc. | Assessing graft suitability for transplantation |
US12098421B2 (en) | 2023-05-15 | 2024-09-24 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8024128B2 (en) * | 2004-09-07 | 2011-09-20 | Gene Security Network, Inc. | System and method for improving clinical decisions by aggregating, validating and analysing genetic and phenotypic data |
US20070178501A1 (en) * | 2005-12-06 | 2007-08-02 | Matthew Rabinowitz | System and method for integrating and validating genotypic, phenotypic and medical information into a database according to a standardized ontology |
US20070027636A1 (en) * | 2005-07-29 | 2007-02-01 | Matthew Rabinowitz | System and method for using genetic, phentoypic and clinical data to make predictions for clinical or lifestyle decisions |
US8515679B2 (en) | 2005-12-06 | 2013-08-20 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US20070122823A1 (en) * | 2005-09-01 | 2007-05-31 | Bianchi Diana W | Amniotic fluid cell-free fetal DNA fragment size pattern for prenatal diagnosis |
CA2632230C (en) * | 2005-11-26 | 2019-05-07 | Gene Security Network, Inc. | System and method for cleaning noisy genetic data and using genetic, phentoypic and clinical data to make predictions |
US20090053719A1 (en) | 2007-08-03 | 2009-02-26 | The Chinese University Of Hong Kong | Analysis of nucleic acids by digital pcr |
US20110027795A1 (en) * | 2008-02-18 | 2011-02-03 | Genetic Technologies Limited | Cell processing and/or enrichment methods |
CA2731086A1 (en) * | 2008-07-18 | 2010-01-21 | Wen-Hua Fan | Non-invasive fetal rhd genotyping from maternal whole blood |
AU2010239131A1 (en) | 2009-04-21 | 2011-11-17 | Genetic Technologies Limited | Methods for obtaining fetal genetic material |
US20110312503A1 (en) | 2010-01-23 | 2011-12-22 | Artemis Health, Inc. | Methods of fetal abnormality detection |
CN103370456A (zh) * | 2010-08-24 | 2013-10-23 | 比奥Dx股份有限公司 | 限定母体循环血液中保守的游离浮动胎儿dna的诊断性和治疗性靶物 |
US10131947B2 (en) * | 2011-01-25 | 2018-11-20 | Ariosa Diagnostics, Inc. | Noninvasive detection of fetal aneuploidy in egg donor pregnancies |
WO2012129363A2 (en) | 2011-03-24 | 2012-09-27 | President And Fellows Of Harvard College | Single cell nucleic acid detection and analysis |
EP2725347B1 (en) * | 2011-06-27 | 2018-09-26 | Olympus Corporation | Method for detecting target particles |
GB2524948A (en) * | 2014-03-07 | 2015-10-14 | Oxford Gene Technology Operations Ltd | Detecting Increase or Decrease in the Amount of a Nucleic Acid having a Sequence of Interest |
MA39951A (fr) | 2014-05-09 | 2017-03-15 | Lifecodexx Ag | Détection de l'adn provenant d'un type spécifique de cellule et méthodes associées |
EP2942400A1 (en) | 2014-05-09 | 2015-11-11 | Lifecodexx AG | Multiplex detection of DNA that originates from a specific cell-type |
KR20160010277A (ko) | 2014-07-18 | 2016-01-27 | 에스케이텔레콤 주식회사 | 산모의 무세포 dna의 차세대 서열분석을 통한 태아의 단일유전자 유전변이의 예측방법 |
EP3359695B1 (en) * | 2015-10-10 | 2020-04-15 | Guardant Health, Inc. | Methods and applications of gene fusion detection in cell-free dna analysis |
EP3168309B8 (en) | 2015-11-10 | 2020-06-03 | Eurofins LifeCodexx GmbH | Detection of foetal chromosomal aneuploidies using dna regions that are differentially methylated between the foetus and the pregnant female |
US11299780B2 (en) | 2016-07-15 | 2022-04-12 | The Regents Of The University Of California | Methods of producing nucleic acid libraries |
AU2017336153B2 (en) | 2016-09-30 | 2023-07-13 | Guardant Health, Inc. | Methods for multi-resolution analysis of cell-free nucleic acids |
US9850523B1 (en) | 2016-09-30 | 2017-12-26 | Guardant Health, Inc. | Methods for multi-resolution analysis of cell-free nucleic acids |
US20200299677A1 (en) | 2017-10-27 | 2020-09-24 | Juno Diagnostics, Inc. | Devices, systems and methods for ultra-low volume liquid biopsy |
WO2019140201A1 (en) | 2018-01-12 | 2019-07-18 | Claret Bioscience, Llc | Methods and compositions for analyzing nucleic acid |
EP3802864A1 (en) | 2018-06-06 | 2021-04-14 | The Regents Of The University Of California | Methods of producing nucleic acid libraries and compositions and kits for practicing same |
KR20210019462A (ko) | 2018-06-18 | 2021-02-22 | 박스알타 인코퍼레이티드 | 플레이트 침전기를 구비한 어셈블리에 접속되기 위한 저부 섹션 및 플레이트 침전기를 구비한 어셈블리 |
TWI725686B (zh) | 2018-12-26 | 2021-04-21 | 財團法人工業技術研究院 | 用於產生液珠的管狀結構及液珠產生方法 |
WO2020160414A1 (en) | 2019-01-31 | 2020-08-06 | Guardant Health, Inc. | Compositions and methods for isolating cell-free dna |
US20220259637A1 (en) | 2019-06-28 | 2022-08-18 | Qiagen Gmbh | Method for enriching nucleic acids by size |
TW202136283A (zh) | 2019-12-12 | 2021-10-01 | 日商武田藥品工業股份有限公司 | 連續性的蛋白質回收方法 |
CA3183597A1 (en) | 2020-05-14 | 2021-11-18 | Sequenom, Inc. | Methods, systems, and compositions for the analysis of cell-free nucleic acids |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5674686A (en) * | 1994-03-28 | 1997-10-07 | Promega Corporation | Allelic ladders for short tandem repeat loci |
US20080071076A1 (en) * | 2003-10-16 | 2008-03-20 | Sequenom, Inc. | Non-invasive detection of fetal genetic traits |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0813442B1 (en) * | 1995-03-08 | 2002-11-20 | Bioseparations, Inc. | Method for enriching rare cell population |
GB9704444D0 (en) * | 1997-03-04 | 1997-04-23 | Isis Innovation | Non-invasive prenatal diagnosis |
NZ535044A (en) | 2002-03-01 | 2008-12-24 | Ravgen Inc | Non-invasive method to determine the genetic sequence of foetal DNA from a sample from a pregnant female thereby detecting any alternation in gene sequence as compared with the wild type sequence |
AU2003268333A1 (en) | 2003-02-28 | 2004-09-28 | Ravgen, Inc. | Methods for detection of genetic disorders |
-
2003
- 2003-10-16 DE DE60328193T patent/DE60328193D1/de not_active Expired - Lifetime
- 2003-10-16 EP EP03405742.2A patent/EP1524321B2/en not_active Expired - Lifetime
- 2003-10-16 AT AT03405742T patent/ATE435301T1/de not_active IP Right Cessation
-
2004
- 2004-10-15 US US10/964,726 patent/US20050164241A1/en not_active Abandoned
- 2004-10-15 JP JP2004301575A patent/JP4705774B2/ja active Active
-
2007
- 2007-09-14 US US11/855,558 patent/US7838647B2/en active Active
-
2010
- 2010-11-12 JP JP2010253675A patent/JP5222926B2/ja active Active
-
2011
- 2011-02-17 US US13/029,999 patent/US20110245482A1/en not_active Abandoned
- 2011-02-17 US US13/029,995 patent/US9580751B2/en active Active
-
2012
- 2012-07-24 US US13/557,025 patent/US20120302741A1/en not_active Abandoned
-
2013
- 2013-02-01 US US13/757,637 patent/US9738931B2/en active Active
- 2013-02-04 JP JP2013019380A patent/JP5728510B2/ja active Active
- 2013-02-27 US US13/779,300 patent/US20130190483A1/en not_active Abandoned
-
2017
- 2017-07-18 US US15/653,401 patent/US20170321279A1/en not_active Abandoned
-
2021
- 2021-05-11 US US17/317,240 patent/US20210262035A1/en active Pending
-
2023
- 2023-12-13 US US18/538,488 patent/US20240182970A1/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5674686A (en) * | 1994-03-28 | 1997-10-07 | Promega Corporation | Allelic ladders for short tandem repeat loci |
US20080071076A1 (en) * | 2003-10-16 | 2008-03-20 | Sequenom, Inc. | Non-invasive detection of fetal genetic traits |
US7838647B2 (en) * | 2003-10-16 | 2010-11-23 | Sequenom, Inc. | Non-invasive detection of fetal genetic traits |
US20110245482A1 (en) * | 2003-10-16 | 2011-10-06 | Sequenom, Inc. | Non-invasive detection of fetal genetic traits |
US20110251076A1 (en) * | 2003-10-16 | 2011-10-13 | Sequenom, Inc. | Non-invasive detection of fetal genetic traits |
Cited By (371)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9580751B2 (en) | 2003-10-16 | 2017-02-28 | Sequenom, Inc. | Non-invasive detection of fetal genetic traits |
US7838647B2 (en) | 2003-10-16 | 2010-11-23 | Sequenom, Inc. | Non-invasive detection of fetal genetic traits |
US20080071076A1 (en) * | 2003-10-16 | 2008-03-20 | Sequenom, Inc. | Non-invasive detection of fetal genetic traits |
US9738931B2 (en) | 2003-10-16 | 2017-08-22 | Sequenom, Inc. | Non-invasive detection of fetal genetic traits |
US9011661B2 (en) | 2004-02-02 | 2015-04-21 | Boreal Genomics, Inc. | Enrichment of nucleic acid targets |
US9534304B2 (en) | 2004-02-02 | 2017-01-03 | The University Of British Columbia | Scodaphoresis and methods and apparatus for moving and concentrating particles |
US10337054B2 (en) | 2004-02-02 | 2019-07-02 | Quantum-Si Incorporated | Enrichment of nucleic acid targets |
US10738351B2 (en) | 2004-02-02 | 2020-08-11 | Quantum-Si Incorporated | Enrichment of nucleic acid targets |
US11795497B2 (en) | 2004-02-02 | 2023-10-24 | Quantum-Si Incorporated | Enrichment of nucleic acid targets |
US8529744B2 (en) | 2004-02-02 | 2013-09-10 | Boreal Genomics Corp. | Enrichment of nucleic acid targets |
US10975421B2 (en) | 2004-02-02 | 2021-04-13 | Quantum-Si Incorporated | Enrichment of nucleic acid targets |
US20090317797A1 (en) * | 2005-01-18 | 2009-12-24 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Non-Invasive, Prenatal, In-Vitro Method for Detecting the Normal Healthy Condition, the Condition of a Healthy Carrier or the Condition of a Carrier Inflicted with Cystic Fibrosis |
US20110129841A1 (en) * | 2005-06-02 | 2011-06-02 | Fluidigm Corporation | Analysis using microfluidic partitioning devices |
US9364829B2 (en) | 2005-06-02 | 2016-06-14 | Fluidigm Corporation | Analysis using microfluidic partitioning devices |
US20110143949A1 (en) * | 2005-06-02 | 2011-06-16 | Fluidigm Corporation | Analysis using microfluidic partitioning devices |
US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US10081839B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc | System and method for cleaning noisy genetic data and determining chromosome copy number |
US10083273B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US10392664B2 (en) | 2005-07-29 | 2019-08-27 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US10227652B2 (en) | 2005-07-29 | 2019-03-12 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US10260096B2 (en) | 2005-07-29 | 2019-04-16 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US12065703B2 (en) | 2005-07-29 | 2024-08-20 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US10266893B2 (en) | 2005-07-29 | 2019-04-23 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US11306359B2 (en) | 2005-11-26 | 2022-04-19 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US10597724B2 (en) | 2005-11-26 | 2020-03-24 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US10240202B2 (en) | 2005-11-26 | 2019-03-26 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US8682592B2 (en) | 2005-11-26 | 2014-03-25 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US10711309B2 (en) | 2005-11-26 | 2020-07-14 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US9430611B2 (en) | 2005-11-26 | 2016-08-30 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US9695477B2 (en) | 2005-11-26 | 2017-07-04 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US20100124751A1 (en) * | 2006-02-02 | 2010-05-20 | The Board Of Trustees Of The Leland Stanford Junior University | Non-Invasive Fetal Genetic Screening by Digital Analysis |
US9441273B2 (en) | 2006-02-02 | 2016-09-13 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive fetal genetic screening by digital analysis |
US8293470B2 (en) | 2006-02-02 | 2012-10-23 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive fetal genetic screening by digital analysis |
US8008018B2 (en) | 2006-02-02 | 2011-08-30 | The Board Of Trustees Of The Leland Stanford Junior University | Determination of fetal aneuploidies by massively parallel DNA sequencing |
EP2385143A2 (en) | 2006-02-02 | 2011-11-09 | The Board of Trustees of the Leland Stanford Junior University | Non-invasive fetal genetic screening by digital analysis |
EP3591068A1 (en) | 2006-02-02 | 2020-01-08 | The Board of Trustees of the Leland Stanford Junior University | Non-invasive fetal genetic screening by digital analysis |
US20100124752A1 (en) * | 2006-02-02 | 2010-05-20 | The Board Of Trustees Of The Leland Stanford Junior University | Non-Invasive Fetal Genetic Screening by Digital Analysis |
EP2423334A2 (en) | 2006-02-02 | 2012-02-29 | The Board of Trustees of The Leland Stanford Junior University | Non-invasive fetal genetic screening by digital analysis |
US9777328B2 (en) | 2006-02-02 | 2017-10-03 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive fetal genetic screening by digital analysis |
US20100255493A1 (en) * | 2006-02-02 | 2010-10-07 | The Board Of Trustees Of The Leland Stanford Junior University | Non-Invasive Fetal Genetic Screening by Digital Analysis |
US20100256013A1 (en) * | 2006-02-02 | 2010-10-07 | The Board Of Trustees Of The Leland Stanford Junior University | Non-Invasive Fetal Genetic Screening by Digital Analysis |
US10072295B2 (en) | 2006-02-02 | 2018-09-11 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive fetal genetic screening by digtal analysis |
EP3002338A1 (en) | 2006-02-02 | 2016-04-06 | The Board of Trustees of The Leland Stanford Junior University | Non-invasive fetal genetic screening by digital analysis |
US20100255492A1 (en) * | 2006-02-02 | 2010-10-07 | The Board Of Trustees Of The Leland Stanford Junior University | Non-Invasive Fetal Genetic Screening by Digital Analysis |
EP3002339A1 (en) | 2006-02-02 | 2016-04-06 | The Board of Trustees of The Leland Stanford Junior University | Non-invasive fetal genetic screening by digital analysis |
US9777329B2 (en) | 2006-02-02 | 2017-10-03 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive fetal genetic screening by digital analysis |
US11692225B2 (en) | 2006-02-02 | 2023-07-04 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive fetal genetic screening by digital analysis |
US10081841B2 (en) | 2006-02-28 | 2018-09-25 | University Of Louisville Research Foundation, Inc. | Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms |
US20110059451A1 (en) * | 2006-02-28 | 2011-03-10 | University Of Louisville Research Foundation | Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms |
US8399195B2 (en) | 2006-02-28 | 2013-03-19 | University Of Louisville Research Foundation, Inc. | Detecting genetic abnormalities |
US8609338B2 (en) | 2006-02-28 | 2013-12-17 | University Of Louisville Research Foundation, Inc. | Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms |
US20110117548A1 (en) * | 2006-02-28 | 2011-05-19 | University Of Louisville Research Foundation, Inc. | Detecting Fetal Chromosomal Abnormalities Using Tandem Single Nucleotide Polymorphisms |
US20100184044A1 (en) * | 2006-02-28 | 2010-07-22 | University Of Louisville Research Foundation | Detecting Genetic Abnormalities |
US8663921B2 (en) | 2006-02-28 | 2014-03-04 | University Of Louisville Research Foundation, Inc. | Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms |
US20100184043A1 (en) * | 2006-02-28 | 2010-07-22 | University Of Louisville Research Foundation | Detecting Genetic Abnormalities |
US20080020390A1 (en) * | 2006-02-28 | 2008-01-24 | Mitchell Aoy T | Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms |
US7799531B2 (en) | 2006-02-28 | 2010-09-21 | University Of Louisville Research Foundation | Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms |
US20090203002A1 (en) * | 2006-03-06 | 2009-08-13 | Columbia University | Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures |
WO2007140417A2 (en) | 2006-05-31 | 2007-12-06 | Sequenom, Inc. | Methods and compositions for the extraction and amplification of nucleic acid from a sample |
US9453257B2 (en) | 2006-05-31 | 2016-09-27 | Sequenom, Inc. | Methods and compositions for the extraction and amplification of nucleic acid from a sample |
EP2602321A1 (en) | 2006-05-31 | 2013-06-12 | Sequenom, Inc. | Methods and compositions for the extraction and amplification of nucleic acid from a sample |
EP3617321A2 (en) | 2006-05-31 | 2020-03-04 | Sequenom, Inc. | Methods and compositions for the extraction and amplification of nucleic acid from a sample |
US8679741B2 (en) | 2006-05-31 | 2014-03-25 | Sequenom, Inc. | Methods and compositions for the extraction and amplification of nucleic acid from a sample |
US11952569B2 (en) | 2006-05-31 | 2024-04-09 | Sequenom, Inc. | Methods and compositions for the extraction and amplification of nucleic acid from a sample |
EP3260556A1 (en) | 2006-05-31 | 2017-12-27 | Sequenom, Inc. | Methods and compositions for the extraction and amplification of nucleic acid from a sample |
US10662421B2 (en) | 2006-05-31 | 2020-05-26 | Sequenom, Inc. | Methods and compositions for the extraction and amplification of nucleic acid from a sample |
US20100297710A1 (en) * | 2006-05-31 | 2010-11-25 | Sequenom, Inc. | Methods and compositions for the extraction and amplification of nucleic acid from a sample |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
US11781187B2 (en) | 2006-06-14 | 2023-10-10 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US11674176B2 (en) | 2006-06-14 | 2023-06-13 | Verinata Health, Inc | Fetal aneuploidy detection by sequencing |
US20080220422A1 (en) * | 2006-06-14 | 2008-09-11 | Daniel Shoemaker | Rare cell analysis using sample splitting and dna tags |
US9273355B2 (en) | 2006-06-14 | 2016-03-01 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US10155984B2 (en) | 2006-06-14 | 2018-12-18 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US8372584B2 (en) | 2006-06-14 | 2013-02-12 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US20080070792A1 (en) * | 2006-06-14 | 2008-03-20 | Roland Stoughton | Use of highly parallel snp genotyping for fetal diagnosis |
US9347100B2 (en) | 2006-06-14 | 2016-05-24 | Gpb Scientific, Llc | Rare cell analysis using sample splitting and DNA tags |
US9017942B2 (en) | 2006-06-14 | 2015-04-28 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US10704090B2 (en) | 2006-06-14 | 2020-07-07 | Verinata Health, Inc. | Fetal aneuploidy detection by sequencing |
US8168389B2 (en) | 2006-06-14 | 2012-05-01 | The General Hospital Corporation | Fetal cell analysis using sample splitting |
US10591391B2 (en) | 2006-06-14 | 2020-03-17 | Verinata Health, Inc. | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
US20080096766A1 (en) * | 2006-06-16 | 2008-04-24 | Sequenom, Inc. | Methods and compositions for the amplification, detection and quantification of nucleic acid from a sample |
US20100261188A1 (en) * | 2006-12-07 | 2010-10-14 | Biocept, Inc. | Non-invasive prenatal genetic screen |
US8652780B2 (en) | 2007-03-26 | 2014-02-18 | Sequenom, Inc. | Restriction endonuclease enhanced polymorphic sequence detection |
US12060614B2 (en) | 2007-07-23 | 2024-08-13 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing |
US9051616B2 (en) | 2007-07-23 | 2015-06-09 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing |
US8442774B2 (en) | 2007-07-23 | 2013-05-14 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using paired end |
US20090029377A1 (en) * | 2007-07-23 | 2009-01-29 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing |
US20100112590A1 (en) * | 2007-07-23 | 2010-05-06 | The Chinese University Of Hong Kong | Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing With Enrichment |
US12018329B2 (en) | 2007-07-23 | 2024-06-25 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing |
US12054780B2 (en) | 2007-07-23 | 2024-08-06 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing |
US12054776B2 (en) | 2007-07-23 | 2024-08-06 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing |
US11142799B2 (en) | 2007-07-23 | 2021-10-12 | The Chinese University Of Hong Kong | Detecting chromosomal aberrations associated with cancer using genomic sequencing |
US8972202B2 (en) | 2007-07-23 | 2015-03-03 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing |
US12065704B2 (en) | 2007-07-23 | 2024-08-20 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing |
US10619214B2 (en) | 2007-07-23 | 2020-04-14 | The Chinese University Of Hong Kong | Detecting genetic aberrations associated with cancer using genomic sequencing |
US9121069B2 (en) | 2007-07-23 | 2015-09-01 | The Chinese University Of Hong Kong | Diagnosing cancer using genomic sequencing |
US10934589B2 (en) | 2008-01-18 | 2021-03-02 | President And Fellows Of Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
US11001894B2 (en) | 2008-01-18 | 2021-05-11 | President And Fellows Of Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
US10934588B2 (en) | 2008-01-18 | 2021-03-02 | President And Fellows Of Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
US8852416B2 (en) | 2008-02-01 | 2014-10-07 | The University Of British Columbia | Methods and apparatus for particle introduction and recovery |
US20110033862A1 (en) * | 2008-02-19 | 2011-02-10 | Gene Security Network, Inc. | Methods for cell genotyping |
US20090317817A1 (en) * | 2008-03-11 | 2009-12-24 | Sequenom, Inc. | Nucleic acid-based tests for prenatal gender determination |
US8709726B2 (en) | 2008-03-11 | 2014-04-29 | Sequenom, Inc. | Nucleic acid-based tests for prenatal gender determination |
US8722336B2 (en) | 2008-03-26 | 2014-05-13 | Sequenom, Inc. | Restriction endonuclease enhanced polymorphic sequence detection |
US20110092763A1 (en) * | 2008-05-27 | 2011-04-21 | Gene Security Network, Inc. | Methods for Embryo Characterization and Comparison |
US9790250B2 (en) | 2008-05-30 | 2017-10-17 | Qiagen Gmbh | Method for isolating short-chain nucleic acids |
US10738069B2 (en) | 2008-05-30 | 2020-08-11 | Qiagen Gmbh | Method for isolating nucleic acids |
US9809612B2 (en) * | 2008-05-30 | 2017-11-07 | Qiagen Gmbh | Method for isolating nucleic acids |
US20110160446A1 (en) * | 2008-05-30 | 2011-06-30 | Qiagen Gmbh | Method for isolating short-chain nucleic acids |
US20110130558A1 (en) * | 2008-05-30 | 2011-06-02 | Qiagen Gmbh | Method for isolating nucleic acids |
US20110178719A1 (en) * | 2008-08-04 | 2011-07-21 | Gene Security Network, Inc. | Methods for Allele Calling and Ploidy Calling |
US9639657B2 (en) | 2008-08-04 | 2017-05-02 | Natera, Inc. | Methods for allele calling and ploidy calling |
US8962247B2 (en) | 2008-09-16 | 2015-02-24 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
US8476013B2 (en) | 2008-09-16 | 2013-07-02 | Sequenom, Inc. | Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
EP3103871A1 (en) | 2008-09-16 | 2016-12-14 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnostic |
US10612086B2 (en) | 2008-09-16 | 2020-04-07 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
US10738358B2 (en) | 2008-09-16 | 2020-08-11 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
EP3770255A1 (en) | 2008-09-16 | 2021-01-27 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
US8296076B2 (en) | 2008-09-20 | 2012-10-23 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuoploidy by sequencing |
US8682594B2 (en) | 2008-09-20 | 2014-03-25 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US9404157B2 (en) | 2008-09-20 | 2016-08-02 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US12054777B2 (en) | 2008-09-20 | 2024-08-06 | The Board Of Trustees Of The Leland Standford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US9353414B2 (en) | 2008-09-20 | 2016-05-31 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US8195415B2 (en) | 2008-09-20 | 2012-06-05 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US10669585B2 (en) | 2008-09-20 | 2020-06-02 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
US8771948B2 (en) | 2009-04-03 | 2014-07-08 | Sequenom, Inc. | Nucleic acid preparation compositions and methods |
US10858645B2 (en) | 2009-04-03 | 2020-12-08 | Sequenom, Inc. | Nucleic acid preparation compositions and methods |
US12077752B2 (en) | 2009-04-03 | 2024-09-03 | Sequenom, Inc. | Nucleic acid preparation compositions and methods |
US9580741B2 (en) | 2009-04-03 | 2017-02-28 | Sequenom, Inc. | Nucleic acid preparation compositions and methods |
US10053685B2 (en) | 2009-04-03 | 2018-08-21 | Sequenom, Inc. | Nucleic acid preparation compositions and methods |
US9850480B2 (en) | 2009-04-03 | 2017-12-26 | Sequenom, Inc. | Nucleic acid preparation compositions and methods |
US8877028B2 (en) | 2009-04-21 | 2014-11-04 | The University Of British Columbia | System and methods for detection of particles |
WO2011034631A1 (en) | 2009-09-16 | 2011-03-24 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
EP3330382A1 (en) | 2009-09-16 | 2018-06-06 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
EP3722440A1 (en) | 2009-09-16 | 2020-10-14 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
US10522242B2 (en) | 2009-09-30 | 2019-12-31 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US10061890B2 (en) | 2009-09-30 | 2018-08-28 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US10061889B2 (en) | 2009-09-30 | 2018-08-28 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US10216896B2 (en) | 2009-09-30 | 2019-02-26 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US9228234B2 (en) | 2009-09-30 | 2016-01-05 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US8467976B2 (en) | 2009-11-05 | 2013-06-18 | The Chinese University Of Hong Kong | Fetal genomic analysis from a maternal biological sample |
US11401551B2 (en) | 2009-11-05 | 2022-08-02 | The Chinese University Of Hong Kong | Identifying a de novo fetal mutation from a maternal biological sample |
EP3783110A1 (en) | 2009-11-05 | 2021-02-24 | The Chinese University Of Hong Kong | Fetal genomic analysis from a maternal biological sample |
EP3241914A1 (en) | 2009-11-05 | 2017-11-08 | The Chinese University Of Hong Kong | Fetal genomic analysis from a maternal biological sample |
US10093976B2 (en) | 2009-11-05 | 2018-10-09 | The Chinese University Of Hong Kong | Identifying a de novo fetal mutation from a maternal biological sample |
US20110105353A1 (en) * | 2009-11-05 | 2011-05-05 | The Chinese University of Hong Kong c/o Technology Licensing Office | Fetal Genomic Analysis From A Maternal Biological Sample |
EP3498863A1 (en) | 2009-11-05 | 2019-06-19 | The Chinese University Of Hong Kong | Fetal genomic analysis from a maternal biological sample |
WO2011057094A1 (en) | 2009-11-05 | 2011-05-12 | The Chinese University Of Hong Kong | Fetal genomic analysis from a maternal biological sample |
US9512480B2 (en) | 2009-11-05 | 2016-12-06 | The Chinese University Of Hong Kong | Determination of the depth coverage of the fetal genome |
EP4170043A1 (en) | 2009-11-05 | 2023-04-26 | The Chinese University Of Hong Kong | Fetal genomic analysis from a maternal biological sample |
US8620593B2 (en) | 2009-11-06 | 2013-12-31 | The Chinese University Of Hong Kong | Size-based genomic analysis |
US9982300B2 (en) | 2009-11-06 | 2018-05-29 | The Chinese University Of Hong Kong | Size-based genomic analysis |
WO2011054936A1 (en) | 2009-11-06 | 2011-05-12 | The Chinese University Of Hong Kong | Size-based genomic analysis |
EP4212630A1 (en) | 2009-11-06 | 2023-07-19 | The Chinese University of Hong Kong | Size-based genomic analysis |
EP3406737A1 (en) | 2009-11-06 | 2018-11-28 | The Chinese University of Hong Kong | Size-based genomic analysis |
US11365448B2 (en) | 2009-11-06 | 2022-06-21 | The Chinese University Of Hong Kong | Size-based genomic analysis |
US9926593B2 (en) | 2009-12-22 | 2018-03-27 | Sequenom, Inc. | Processes and kits for identifying aneuploidy |
US11180799B2 (en) | 2009-12-22 | 2021-11-23 | Sequenom, Inc. | Processes and kits for identifying aneuploidy |
US10662474B2 (en) | 2010-01-19 | 2020-05-26 | Verinata Health, Inc. | Identification of polymorphic sequences in mixtures of genomic DNA by whole genome sequencing |
EP3636776A1 (en) | 2010-02-19 | 2020-04-15 | Sequenom, Inc. | Methods for analysing nucleic acid sequence information using gc bias, optionally for detecting fetal nucleic acid abnormalities |
US8426122B2 (en) | 2010-03-11 | 2013-04-23 | Cellscape Corporation | Method and device for identification of nucleated red blood cells from a maternal blood sample |
US8774488B2 (en) | 2010-03-11 | 2014-07-08 | Cellscape Corporation | Method and device for identification of nucleated red blood cells from a maternal blood sample |
US11312996B2 (en) | 2010-05-18 | 2022-04-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US9163282B2 (en) | 2010-05-18 | 2015-10-20 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US10113196B2 (en) | 2010-05-18 | 2018-10-30 | Natera, Inc. | Prenatal paternity testing using maternal blood, free floating fetal DNA and SNP genotyping |
US10174369B2 (en) | 2010-05-18 | 2019-01-08 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US10017812B2 (en) | 2010-05-18 | 2018-07-10 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11482300B2 (en) | 2010-05-18 | 2022-10-25 | Natera, Inc. | Methods for preparing a DNA fraction from a biological sample for analyzing genotypes of cell-free DNA |
US10793912B2 (en) | 2010-05-18 | 2020-10-06 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
US11519035B2 (en) | 2010-05-18 | 2022-12-06 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11525162B2 (en) | 2010-05-18 | 2022-12-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US10526658B2 (en) | 2010-05-18 | 2020-01-07 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US10774380B2 (en) | 2010-05-18 | 2020-09-15 | Natera, Inc. | Methods for multiplex PCR amplification of target loci in a nucleic acid sample |
US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US10538814B2 (en) | 2010-05-18 | 2020-01-21 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US10557172B2 (en) | 2010-05-18 | 2020-02-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11746376B2 (en) | 2010-05-18 | 2023-09-05 | Natera, Inc. | Methods for amplification of cell-free DNA using ligated adaptors and universal and inner target-specific primers for multiplexed nested PCR |
US10731220B2 (en) | 2010-05-18 | 2020-08-04 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11111545B2 (en) | 2010-05-18 | 2021-09-07 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US10590482B2 (en) | 2010-05-18 | 2020-03-17 | Natera, Inc. | Amplification of cell-free DNA using nested PCR |
US8825412B2 (en) | 2010-05-18 | 2014-09-02 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US10655180B2 (en) | 2010-05-18 | 2020-05-19 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US10597723B2 (en) | 2010-05-18 | 2020-03-24 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11306357B2 (en) | 2010-05-18 | 2022-04-19 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US9334541B2 (en) | 2010-05-18 | 2016-05-10 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US8949036B2 (en) | 2010-05-18 | 2015-02-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11286530B2 (en) | 2010-05-18 | 2022-03-29 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US12020778B2 (en) | 2010-05-18 | 2024-06-25 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
WO2011156387A2 (en) | 2010-06-07 | 2011-12-15 | Esoterix Genetic Laboratories, Llc | Enumeration of nucleic acids |
WO2012012725A2 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting diseases or conditions using phagocytic cells |
EP4303584A2 (en) | 2010-07-23 | 2024-01-10 | President and Fellows of Harvard College | Methods for detecting signatures of disease or conditions in bodily fluids |
US10961578B2 (en) | 2010-07-23 | 2021-03-30 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
US11111537B2 (en) | 2010-07-23 | 2021-09-07 | President And Fellows Of Harvard College | Methods of detecting autoimmune or immune-related diseases or conditions |
US10907198B2 (en) * | 2010-08-06 | 2021-02-02 | Ariosa Diagnostics, Inc. | Assay systems for genetic analysis |
US20190169681A1 (en) * | 2010-08-06 | 2019-06-06 | Ariosa Diagnostics, Inc. | Assay systems for genetic analysis |
WO2012114075A1 (en) | 2011-02-25 | 2012-08-30 | University Of Plymouth | Method for processing maternal and fetal dna |
US8455221B2 (en) | 2011-04-29 | 2013-06-04 | Sequenom, Inc. | Quantification of a minority nucleic acid species |
US8450061B2 (en) | 2011-04-29 | 2013-05-28 | Sequenom, Inc. | Quantification of a minority nucleic acid species |
US8460872B2 (en) | 2011-04-29 | 2013-06-11 | Sequenom, Inc. | Quantification of a minority nucleic acid species |
US8518228B2 (en) | 2011-05-20 | 2013-08-27 | The University Of British Columbia | Systems and methods for enhanced SCODA |
US10829800B2 (en) | 2011-05-20 | 2020-11-10 | The University Of British Columbia | Systems and methods for enhanced SCODA |
US9434938B2 (en) | 2011-05-20 | 2016-09-06 | The University Of British Columbia | Systems and methods for enhanced SCODA |
US10400266B2 (en) | 2011-05-20 | 2019-09-03 | The University Of British Columbia | Systems and methods for enhanced SCODA |
US11004537B2 (en) | 2011-06-24 | 2021-05-11 | Sequenom, Inc. | Methods and processes for non invasive assessment of a genetic variation |
US9547748B2 (en) | 2011-06-29 | 2017-01-17 | Bgi Health Service Co., Ltd. | Method for determining fetal chromosomal abnormality |
US11437121B2 (en) | 2011-10-06 | 2022-09-06 | Sequenom, Inc. | Methods and processes for non-invasive detection of a microduplication or a microdeletion with reduced sequence read count error |
US11001884B2 (en) | 2011-10-06 | 2021-05-11 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US9984198B2 (en) | 2011-10-06 | 2018-05-29 | Sequenom, Inc. | Reducing sequence read count error in assessment of complex genetic variations |
US10323268B2 (en) | 2011-10-06 | 2019-06-18 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US11492659B2 (en) | 2011-10-06 | 2022-11-08 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US11560586B2 (en) | 2011-10-06 | 2023-01-24 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10196681B2 (en) | 2011-10-06 | 2019-02-05 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10424394B2 (en) | 2011-10-06 | 2019-09-24 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US9367663B2 (en) | 2011-10-06 | 2016-06-14 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
WO2013075100A1 (en) * | 2011-11-17 | 2013-05-23 | Cellscape Corporation | Methods, devices, and kits for obtaining and analyzing cells |
US9555354B2 (en) | 2012-01-13 | 2017-01-31 | The University Of British Columbia | Multiple arm apparatus and methods for separation of particles |
US9186685B2 (en) | 2012-01-13 | 2015-11-17 | The University Of British Columbia | Multiple arm apparatus and methods for separation of particles |
US11697849B2 (en) | 2012-01-20 | 2023-07-11 | Sequenom, Inc. | Methods for non-invasive assessment of fetal genetic variations that factor experimental conditions |
US11312997B2 (en) | 2012-03-02 | 2022-04-26 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10738359B2 (en) | 2012-03-02 | 2020-08-11 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US9605313B2 (en) | 2012-03-02 | 2017-03-28 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
US10741270B2 (en) | 2012-03-08 | 2020-08-11 | The Chinese University Of Hong Kong | Size-based analysis of cell-free tumor DNA for classifying level of cancer |
US11031100B2 (en) | 2012-03-08 | 2021-06-08 | The Chinese University Of Hong Kong | Size-based sequencing analysis of cell-free tumor DNA for classifying level of cancer |
US10297342B2 (en) | 2012-03-08 | 2019-05-21 | The Chinese University Of Hong Kong | Classification of cancer level based on genomic coordinates of outermost nucleotides of cell-free DNA |
US11217330B2 (en) | 2012-03-08 | 2022-01-04 | The Chinese University Of Hong Kong | Size-based analysis of fetal DNA fraction in plasma |
US9512477B2 (en) | 2012-05-04 | 2016-12-06 | Boreal Genomics Inc. | Biomarker anaylsis using scodaphoresis |
US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
US11306354B2 (en) | 2012-05-21 | 2022-04-19 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
US9840732B2 (en) | 2012-05-21 | 2017-12-12 | Fluidigm Corporation | Single-particle analysis of particle populations |
US11261494B2 (en) | 2012-06-21 | 2022-03-01 | The Chinese University Of Hong Kong | Method of measuring a fractional concentration of tumor DNA |
US10497461B2 (en) | 2012-06-22 | 2019-12-03 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
WO2014011928A1 (en) | 2012-07-13 | 2014-01-16 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
US11332791B2 (en) | 2012-07-13 | 2022-05-17 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
US10683556B2 (en) | 2012-09-04 | 2020-06-16 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US12054783B2 (en) | 2012-09-04 | 2024-08-06 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10995376B1 (en) | 2012-09-04 | 2021-05-04 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10793916B2 (en) | 2012-09-04 | 2020-10-06 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US11001899B1 (en) | 2012-09-04 | 2021-05-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10041127B2 (en) | 2012-09-04 | 2018-08-07 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10738364B2 (en) | 2012-09-04 | 2020-08-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US11773453B2 (en) | 2012-09-04 | 2023-10-03 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10894974B2 (en) | 2012-09-04 | 2021-01-19 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US11879158B2 (en) | 2012-09-04 | 2024-01-23 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US11913065B2 (en) | 2012-09-04 | 2024-02-27 | Guardent Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10501810B2 (en) | 2012-09-04 | 2019-12-10 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10961592B2 (en) | 2012-09-04 | 2021-03-30 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10501808B2 (en) | 2012-09-04 | 2019-12-10 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10494678B2 (en) | 2012-09-04 | 2019-12-03 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10947600B2 (en) | 2012-09-04 | 2021-03-16 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US11319598B2 (en) | 2012-09-04 | 2022-05-03 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US11319597B2 (en) | 2012-09-04 | 2022-05-03 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10822663B2 (en) | 2012-09-04 | 2020-11-03 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US9840743B2 (en) | 2012-09-04 | 2017-12-12 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10837063B2 (en) | 2012-09-04 | 2020-11-17 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10876171B2 (en) | 2012-09-04 | 2020-12-29 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US9834822B2 (en) | 2012-09-04 | 2017-12-05 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US12049673B2 (en) | 2012-09-04 | 2024-07-30 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US9598731B2 (en) | 2012-09-04 | 2017-03-21 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US9902992B2 (en) | 2012-09-04 | 2018-02-27 | Guardant Helath, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10876172B2 (en) | 2012-09-04 | 2020-12-29 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10457995B2 (en) | 2012-09-04 | 2019-10-29 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10876152B2 (en) | 2012-09-04 | 2020-12-29 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US11434523B2 (en) | 2012-09-04 | 2022-09-06 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10482994B2 (en) | 2012-10-04 | 2019-11-19 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10504613B2 (en) | 2012-12-20 | 2019-12-10 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10497462B2 (en) | 2013-01-25 | 2019-12-03 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10494675B2 (en) | 2013-03-09 | 2019-12-03 | Cell Mdx, Llc | Methods of detecting cancer |
US12037645B2 (en) | 2013-03-09 | 2024-07-16 | Immunis.Ai, Inc. | Methods of detecting cancer |
US11585814B2 (en) | 2013-03-09 | 2023-02-21 | Immunis.Ai, Inc. | Methods of detecting prostate cancer |
US11060145B2 (en) | 2013-03-13 | 2021-07-13 | Sequenom, Inc. | Methods and compositions for identifying presence or absence of hypermethylation or hypomethylation locus |
US10106836B2 (en) | 2013-03-15 | 2018-10-23 | The Chinese University Of Hong Kong | Determining fetal genomes for multiple fetus pregnancies |
US9340835B2 (en) | 2013-03-15 | 2016-05-17 | Boreal Genomics Corp. | Method for separating homoduplexed and heteroduplexed nucleic acids |
US10930368B2 (en) | 2013-04-03 | 2021-02-23 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10699800B2 (en) | 2013-05-24 | 2020-06-30 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US11462298B2 (en) | 2013-05-24 | 2022-10-04 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10622094B2 (en) | 2013-06-21 | 2020-04-14 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US11326204B2 (en) | 2013-08-19 | 2022-05-10 | Invitae Corporation | Assays for single molecule detection and use thereof |
US9499870B2 (en) | 2013-09-27 | 2016-11-22 | Natera, Inc. | Cell free DNA diagnostic testing standards |
US10577655B2 (en) | 2013-09-27 | 2020-03-03 | Natera, Inc. | Cell free DNA diagnostic testing standards |
US10964409B2 (en) | 2013-10-04 | 2021-03-30 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10438691B2 (en) | 2013-10-07 | 2019-10-08 | Sequenom, Inc. | Non-invasive assessment of chromosome alterations using change in subsequence mappability |
US11929146B2 (en) | 2013-10-07 | 2024-03-12 | Sequenom, Inc. | Systems for non-invasive assessment of chromosome alterations using changes in subsequence mappability |
US11667967B2 (en) | 2013-12-28 | 2023-06-06 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
US11767556B2 (en) | 2013-12-28 | 2023-09-26 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
US10883139B2 (en) | 2013-12-28 | 2021-01-05 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
US11118221B2 (en) | 2013-12-28 | 2021-09-14 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
US11767555B2 (en) | 2013-12-28 | 2023-09-26 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
US10889858B2 (en) | 2013-12-28 | 2021-01-12 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
US10801063B2 (en) | 2013-12-28 | 2020-10-13 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
US11649491B2 (en) | 2013-12-28 | 2023-05-16 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
US11434531B2 (en) | 2013-12-28 | 2022-09-06 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
US11639525B2 (en) | 2013-12-28 | 2023-05-02 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
US11639526B2 (en) | 2013-12-28 | 2023-05-02 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
US12024745B2 (en) | 2013-12-28 | 2024-07-02 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
US12054774B2 (en) | 2013-12-28 | 2024-08-06 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
US12024746B2 (en) | 2013-12-28 | 2024-07-02 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
US11149306B2 (en) | 2013-12-28 | 2021-10-19 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
US11149307B2 (en) | 2013-12-28 | 2021-10-19 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
US11959139B2 (en) | 2013-12-28 | 2024-04-16 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
US9920366B2 (en) | 2013-12-28 | 2018-03-20 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
US10704086B2 (en) | 2014-03-05 | 2020-07-07 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US11447813B2 (en) | 2014-03-05 | 2022-09-20 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10870880B2 (en) | 2014-03-05 | 2020-12-22 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10982265B2 (en) | 2014-03-05 | 2021-04-20 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US11091796B2 (en) | 2014-03-05 | 2021-08-17 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US11091797B2 (en) | 2014-03-05 | 2021-08-17 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US11667959B2 (en) | 2014-03-05 | 2023-06-06 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10704085B2 (en) | 2014-03-05 | 2020-07-07 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US11365447B2 (en) | 2014-03-13 | 2022-06-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11319596B2 (en) | 2014-04-21 | 2022-05-03 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
US11390916B2 (en) | 2014-04-21 | 2022-07-19 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11408037B2 (en) | 2014-04-21 | 2022-08-09 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
US10179937B2 (en) | 2014-04-21 | 2019-01-15 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
US11486008B2 (en) | 2014-04-21 | 2022-11-01 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
US11530454B2 (en) | 2014-04-21 | 2022-12-20 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
US11371100B2 (en) | 2014-04-21 | 2022-06-28 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
US10597709B2 (en) | 2014-04-21 | 2020-03-24 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11319595B2 (en) | 2014-04-21 | 2022-05-03 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
US10351906B2 (en) | 2014-04-21 | 2019-07-16 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11414709B2 (en) | 2014-04-21 | 2022-08-16 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
US10597708B2 (en) | 2014-04-21 | 2020-03-24 | Natera, Inc. | Methods for simultaneous amplifications of target loci |
US10262755B2 (en) | 2014-04-21 | 2019-04-16 | Natera, Inc. | Detecting cancer mutations and aneuploidy in chromosomal segments |
US11352670B2 (en) | 2014-07-25 | 2022-06-07 | University Of Washington | Methods of determining tissues and/or cell types giving rise to cell-free DNA, and methods of identifying a disease or disorder using same |
US11783911B2 (en) | 2014-07-30 | 2023-10-10 | Sequenom, Inc | Methods and processes for non-invasive assessment of genetic variations |
US10626464B2 (en) | 2014-09-11 | 2020-04-21 | Cell Mdx, Llc | Methods of detecting prostate cancer |
US10364467B2 (en) | 2015-01-13 | 2019-07-30 | The Chinese University Of Hong Kong | Using size and number aberrations in plasma DNA for detecting cancer |
US11168370B2 (en) | 2015-02-10 | 2021-11-09 | The Chinese University Of Hong Kong | Detecting mutations for cancer screening |
US10240209B2 (en) | 2015-02-10 | 2019-03-26 | The Chinese University Of Hong Kong | Detecting mutations for cancer screening |
US11739371B2 (en) | 2015-02-18 | 2023-08-29 | Invitae Corporation | Arrays for single molecule detection and use thereof |
US11168351B2 (en) | 2015-03-05 | 2021-11-09 | Streck, Inc. | Stabilization of nucleic acids in urine |
US11946101B2 (en) | 2015-05-11 | 2024-04-02 | Natera, Inc. | Methods and compositions for determining ploidy |
US11479812B2 (en) | 2015-05-11 | 2022-10-25 | Natera, Inc. | Methods and compositions for determining ploidy |
US11130986B2 (en) | 2015-05-20 | 2021-09-28 | Quantum-Si Incorporated | Method for isolating target nucleic acid using heteroduplex binding proteins |
US11898196B2 (en) | 2015-05-20 | 2024-02-13 | Quantum-Si Incorporated | Method for isolating target nucleic acid using heteroduplex binding proteins |
US11299764B2 (en) | 2015-11-20 | 2022-04-12 | Streck, Inc. | Single spin process for blood plasma separation and plasma composition including preservative |
US11242569B2 (en) | 2015-12-17 | 2022-02-08 | Guardant Health, Inc. | Methods to determine tumor gene copy number by analysis of cell-free DNA |
US11708574B2 (en) | 2016-06-10 | 2023-07-25 | Myriad Women's Health, Inc. | Nucleic acid sequencing adapters and uses thereof |
US11200963B2 (en) | 2016-07-27 | 2021-12-14 | Sequenom, Inc. | Genetic copy number alteration classifications |
US11506655B2 (en) | 2016-07-29 | 2022-11-22 | Streck, Inc. | Suspension composition for hematology analysis control |
US11854666B2 (en) | 2016-09-29 | 2023-12-26 | Myriad Women's Health, Inc. | Noninvasive prenatal screening using dynamic iterative depth optimization |
US11485996B2 (en) | 2016-10-04 | 2022-11-01 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
US11459616B2 (en) | 2016-10-24 | 2022-10-04 | The Chinese University Of Hong Kong | Methods and systems for tumor detection |
US11519028B2 (en) | 2016-12-07 | 2022-12-06 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
US11530442B2 (en) | 2016-12-07 | 2022-12-20 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
US10533219B2 (en) | 2016-12-07 | 2020-01-14 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
US10577650B2 (en) | 2016-12-07 | 2020-03-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
US11694768B2 (en) | 2017-01-24 | 2023-07-04 | Sequenom, Inc. | Methods and processes for assessment of genetic variations |
US10633713B2 (en) | 2017-01-25 | 2020-04-28 | The Chinese University Of Hong Kong | Diagnostic applications using nucleic acid fragments |
US11479825B2 (en) | 2017-01-25 | 2022-10-25 | The Chinese University Of Hong Kong | Diagnostic applications using nucleic acid fragments |
US10894976B2 (en) | 2017-02-21 | 2021-01-19 | Natera, Inc. | Compositions, methods, and kits for isolating nucleic acids |
US11232850B2 (en) | 2017-03-24 | 2022-01-25 | Myriad Genetics, Inc. | Copy number variant caller |
US12084720B2 (en) | 2017-12-14 | 2024-09-10 | Natera, Inc. | Assessing graft suitability for transplantation |
US12024738B2 (en) | 2018-04-14 | 2024-07-02 | Natera, Inc. | Methods for cancer detection and monitoring |
US11525159B2 (en) | 2018-07-03 | 2022-12-13 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
US12011716B2 (en) | 2019-10-29 | 2024-06-18 | Quantum-Si Incorporated | Peristaltic pumping of fluids and associated methods, systems, and devices |
WO2021174079A3 (en) * | 2020-02-28 | 2021-12-16 | Laboratory Corporation Of America Holdings | Compositions, methods, and systems for paternity determination |
US12100478B2 (en) | 2020-07-21 | 2024-09-24 | Natera, Inc. | Method for non-invasive prenatal testing using parental mosaicism data |
US12098421B2 (en) | 2023-05-15 | 2024-09-24 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
US12098422B2 (en) | 2023-12-13 | 2024-09-24 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
Also Published As
Publication number | Publication date |
---|---|
JP5222926B2 (ja) | 2013-06-26 |
JP5728510B2 (ja) | 2015-06-03 |
US20130190483A1 (en) | 2013-07-25 |
US20080071076A1 (en) | 2008-03-20 |
ATE435301T1 (de) | 2009-07-15 |
US20110245482A1 (en) | 2011-10-06 |
EP1524321B2 (en) | 2014-07-23 |
JP2013121359A (ja) | 2013-06-20 |
JP2011087584A (ja) | 2011-05-06 |
US20170321279A1 (en) | 2017-11-09 |
US20110251076A1 (en) | 2011-10-13 |
US20240182970A1 (en) | 2024-06-06 |
US7838647B2 (en) | 2010-11-23 |
US20140193808A1 (en) | 2014-07-10 |
JP4705774B2 (ja) | 2011-06-22 |
EP1524321B1 (en) | 2009-07-01 |
JP2005160470A (ja) | 2005-06-23 |
US20120302741A1 (en) | 2012-11-29 |
DE60328193D1 (de) | 2009-08-13 |
US20210262035A1 (en) | 2021-08-26 |
EP1524321A1 (en) | 2005-04-20 |
US9738931B2 (en) | 2017-08-22 |
US9580751B2 (en) | 2017-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20240182970A1 (en) | Non-invasive detection of fetal genetic traits | |
US10718020B2 (en) | Methods of fetal abnormality detection | |
EP0994963B1 (en) | Non-invasive prenatal diagnosis | |
EP2952589A1 (en) | Noninvasive diagnosis of fetal aneuploidy by sequencing | |
Tozzo et al. | Deletion of amelogenin Y-locus in forensics: literature revision and description of a novel method for sex confirmation | |
CN103534591A (zh) | 通过测序分析进行的非侵入性胎儿遗传筛选 | |
De la Concha et al. | MHC susceptibility genes to IgA deficiency are located in different regions on different HLA haplotypes | |
WO1999061659A1 (en) | A novel str marker system for dna fingerprinting | |
Pfitzinger et al. | Sex determination of forensic samples: co-amplification and simultaneous detection of a Y-specific and an X-specific DNA sequence | |
Sirchia et al. | Trisomic zygote rescue revealed by DNA polymorphism analysis in confined placental mosaicism | |
US6156510A (en) | Polymorphisms in a microsatellite region of a glucocorticoid receptor gene | |
RU2800084C2 (ru) | Способ получения молекулярных STR-маркеров Х-хромосомы для идентификации неизвестного индивида и определения биологического родства для работы с образцами малых количеств ДНК и набор олигонуклеотидов для его осуществления | |
Budowle et al. | The application of PCR to forensic science | |
Heath et al. | The use of a highly informative CA repeat polymorphism within the abetalipoproteinaemia locus (4q22–24) | |
EP2149612A1 (en) | Genetic markers of response to efalizumab | |
AU2015202167B2 (en) | Noninvasive diagnosis of fetal aneuploidy by sequencing | |
CA2390670C (en) | Method of determining susceptibility to bipolar disorders | |
CN117925806A (zh) | 一种基于CRISPR/Cas13a的ABO血型基因型鉴定方法及所用组合物 | |
Baasner et al. | Allele and genotype frequencies for the STR locus D18S51 in a Western German population | |
Nagy et al. | Prenatal Detection of the Δf 508 Mutation Using Fluorescent Pcr and Comparison of the Results with Conventional PCR | |
Kocheva et al. | Prenatal Diagnosis in Macedonian Duchenne Muscular Dystrophy Families |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SEQUENOM, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:UNIVERSITY HOSPITAL OF BASEL;REEL/FRAME:019284/0019 Effective date: 20070214 Owner name: UNIVERSITY HOSPITAL OF BASEL, SWITZERLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HAHN, SINUHE;HOLZGREVE, WOLFGANG;LI, YING;AND OTHERS;REEL/FRAME:019284/0013;SIGNING DATES FROM 20070127 TO 20070131 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |